Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.66
-0.09 (-1.57%)
Nov 4, 2024, 4:00 PM EST - Market closed
Solid Biosciences Employees
Solid Biosciences had 88 employees as of December 31, 2023. The number of employees increased by 1 or 1.15% compared to the previous year.
Employees
88
Change (1Y)
1
Growth (1Y)
1.15%
Revenue / Employee
n/a
Profits / Employee
-$1,030,580
Market Cap
218.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Lifecore Biomedical | 524 |
Utah Medical Products | 190 |
Mersana Therapeutics | 123 |
XBiotech | 82 |
Eton Pharmaceuticals | 30 |
Trevi Therapeutics | 25 |
Benitec Biopharma | 16 |
SLDB News
- 4 weeks ago - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 4 months ago - Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results - GlobeNewsWire
- 7 months ago - Buy Solid Biosciences: Unpacking Its Main Value Driver - Seeking Alpha
- 7 months ago - Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 - GlobeNewsWire
- 8 months ago - Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results - GlobeNewsWire